glp-1 aspiration 🇬🇧 Perioperative Management of New Popular Agents: Agonists (GLP-1 RA: semaglutide, tirzepatide) These drugs delay gastric emptying → patients may have a “full stomach” despite fasting This increases risk of regurgitation New CMS Quality Measure Tied

After stopping, it takes roughly 5 half-lives (about 30 days) for the compound to clear

Bunck MC, Eliasson B, Cornr A, et al

Why UK Demand Is Higher Than Other Countries Wegovy shortages limited NHS eligibility rising obesity rates fitness community interest metabolic research popularity early hype around triple-agonist drugs Retatrutide is already viewed as the next-generation upgrade to semaglutide and tirzepatide, which drives search queries and anticipation

But if you notice a steady weight gain, dont wait reach out to your healthcare provider to discuss possible adjustments

Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Pratley RE